152 related articles for article (PubMed ID: 6778346)
1. Efficacy of pneumococcal vaccination against recurrent otitis media. Preliminary results of a field trial in Finland.
Karma P; Luotonen J; Timonen M; Pöntynen S; Pukander J; Herva E; Grönroos P; Leinonen M; Sibakov M; Mäkelä PH
Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):357-62. PubMed ID: 6778346
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal vaccine and otitis media.
Mäkelä PH; Sibakov M; Herva E; Henrichsen J; Luotonen J; Timonen M; Leinonen M; Koskela M; Pukander J; Pöntynen S; Grönroos P; Karma P
Lancet; 1980 Sep; 2(8194):547-51. PubMed ID: 6106735
[TBL] [Abstract][Full Text] [Related]
3. A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.
Mäkelä PH; Leinonen M; Pukander J; Karma P
Rev Infect Dis; 1981; 3 Suppl():S124-32. PubMed ID: 6974386
[TBL] [Abstract][Full Text] [Related]
4. Passive immunization for the prevention of otitis media.
Englund JA; Glezen WP
Vaccine; 2000 Dec; 19 Suppl 1():S116-21. PubMed ID: 11163474
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
[TBL] [Abstract][Full Text] [Related]
6. Possibilities of preventing otitis media by vaccination.
Mäkelä PH; Karma P; Sipilä M; Pukander J; Leinonen M
Scand J Infect Dis Suppl; 1983; 39():34-8. PubMed ID: 6359378
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
8. Prevention of otitis media in children by pneumococcal vaccination.
Karma P; Pukander J; Sipilä M; Timonen M; Pöntynen S; Herva E; Grönroos P; Mäkelä H
Am J Otolaryngol; 1985; 6(3):173-84. PubMed ID: 3893185
[TBL] [Abstract][Full Text] [Related]
9. A Cross-Reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-Mediated Acute Otitis Media.
Rowe HM; Mann B; Iverson A; Poole A; Tuomanen E; Rosch JW
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308088
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
[TBL] [Abstract][Full Text] [Related]
11. [Acute otitis media in the era of pneumococcal vaccination].
Baquero-Artigao F; del Castillo F
Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):505-9. PubMed ID: 19094865
[TBL] [Abstract][Full Text] [Related]
12. Otitis media: prospects for prevention.
Haggard M
Vaccine; 2008 Dec; 26 Suppl 7():G20-4. PubMed ID: 19094934
[TBL] [Abstract][Full Text] [Related]
13. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
Ahman H; Käyhty H; Tamminen P; Vuorela A; Malinoski F; Eskola J
Pediatr Infect Dis J; 1996 Feb; 15(2):134-9. PubMed ID: 8822286
[TBL] [Abstract][Full Text] [Related]
14. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
Koskela M
Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
[TBL] [Abstract][Full Text] [Related]
16. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
BMC Pediatr; 2015 Oct; 15():162. PubMed ID: 26482232
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal vaccine and otitis media in infancy.
Mäkelä PH; Karma P; Leinonen MK
Bull Eur Physiopathol Respir; 1983; 19(2):235-8. PubMed ID: 6871501
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
Cilveti R; Olmo M; Pérez-Jove J; Picazo JJ; Arimany JL; Mora E; Pérez-Porcuna TM; Aguilar I; Alonso A; Molina F; Del Amo M; Mendez C;
PLoS One; 2017; 12(2):e0170316. PubMed ID: 28146590
[TBL] [Abstract][Full Text] [Related]
19. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
Peltola H; Käyhty H; Sivonen A; Mäkelä H
Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama.
Sloyer JL; Ploussard JH; Howie VM
Rev Infect Dis; 1981; 3 Suppl():S119-23. PubMed ID: 7280444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
